Once issued, this patent will provide protection in Japan until 2029. The claims under the patent cover composition of matter and methods of use for combining Advaxis’s proprietary
The data were presented in the late-breaking session at the 2014 World Transplant Conference (WTC) in San Francisco, CA by Dr. V. Ram Peddi, Director of Kidney Transplant
"ALPHAEON’s acquisition of PRN brings together world renowned ophthalmologists and a premier physician recommended line of nutriceutical products that benefit patients," said CEO Robert E. Grant. "Over the
The current Upsher-Smith Galaxy Portfolio includes seven frequently prescribed AEDs which represent more than one out of every three prescriptions written for seizure disorders. The launch of the
Penn Pharmaceuticals is a UK based global provider of specialist pharmaceutical services providing selected Contract Development and Manufacturing Organisation (CDMO) services to a global customer base to support
Zydelig was approved by the U.S. Food and Drug Administration on July 23, 2014 for the treatment of three B-cell blood cancers. "We are pleased to partner with
According to Aparna Krishnan, MS, GlobalData’s Analyst, and Joshua Owide, GlobalData’s Director of Healthcare Industry Dynamics, the rationale for the deal consisted of a mix of portfolio diversification,
The company announces that it has achieved effective knock-down of the expression of a target gene in the brain in a sequence-specific manner. Independent analysis of brain tissue
DIL is a world leader in developing and providing the finest products in food technology today. Under the terms of the agreement, DIL will manufacture and supply Fortetropin
TransCelerate BioPharma Inc. is dedicated to making the research and development process more efficient across the pharmaceutical industry. The Shared Investigator Platform, which will be built as an
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.